Zdravstveni dom Koper
Koper, Urban Municipality of Koper, 6000, Slovenia
NCT Number: NCT07818993
This study evaluated whether a 2-week course of functional magnetic stimulation applied to the plantar region of the foot could improve sensory function, foot muscle force, postural control, and functional mobility in adults with type 2 diabetes mellitus and diabetic peripheral neuropathy. Participants were assigned to active functional magnetic stimulation or sham stimulation. The study hypothesis was that repeated functional magnetic stimulation would improve sensory and motor function and lead to better functional performance compared with sham stimulation.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Koper, Urban Municipality of Koper, 6000, Slovenia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pulsed magnetic stimulation was delivered to the plantar region of the foot using the FMS Stym device (Iskra Medical, Slovenia). Participants completed 12 sessions over 2 weeks, each lasting 20 minute
Sham treatment reproduced the positioning, appearance, schedule, and duration of active functional magnetic stimulation while a metal plate substantially attenuated the magnetic field reaching the foo
Time frame: Baseline and after 2 weeks of intervention (after 12 sessions)
Participants rose from a chair, walked 3.6 m, turned, walked back to the chair, and sat down. Completion time was recorded in seconds. Lower values indicate better functional mobility.
Time frame: Baseline and after 2 weeks of intervention (after 12 sessions)
Hallux grip force was measured in Newtons using the Enhanced Paper Grip Test. Three measurements were performed for each foot, and the outcome was the average across both feet and three trials. Higher values indicate greater foot grip force.
Time frame: Baseline and after 2 weeks of intervention (after 12 sessions)
Postural sway was assessed during three 30-second barefoot parallel-stance trials on a force platform. Global center-of-pressure sway velocity was expressed in mm/s and averaged across the three trials. Higher values indicate greater postural sway.
Time frame: Baseline and after 2 weeks of intervention (after 12 sessions)
Tactile pressure perception was assessed bilaterally using a 10-g Semmes-Weinstein monofilament at five anatomical sites on each foot. Each site was tested three times. Perceived stimuli were scored 1 and unperceived stimuli 0, giving a total score from 0 to 30. Higher scores indicate better tactile pressure perception
Time frame: Baseline and after 2 weeks of intervention (after 12 sessions)
Vibration perception threshold was assessed bilaterally at five foot locations using a 100-Hz biothesiometer with an output range of 0-50 V. Lower thresholds indicate better vibration perception. Failure to perceive the maximum 50-V stimulus was classified as an undetected measurement.
Looking for future studies?
Notify MeUniversity of Primorska
Other
Effects of Functional Magnetic Stimulation on Sensory, Motor, and Functional Outcomes in Individuals With Diabetic Peripheral Neuropathy: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06797869
Diabetes Mellitus, Diabetes Mellitus, Type 2
La Mesa, California, United States
View Trial DetailsNCT07616661
Diabetic Peripheral Neuropathy
Faisalābad, Punjab Province, Pakistan
View Trial DetailsNCT06074562
Diabetic Peripheral Neuropathy
Chandler, Arizona, United States
View Trial DetailsNCT07725419
Cardiovascular Diseases, Diabetes Complications
Johannesburg, Gauteng, South Africa
View Trial Details